The Myotonic Dystrophy Type 1 Test is a specialized genetic test designed to diagnose Myotonic Dystrophy Type 1 (DM1), a form of muscular dystrophy characterized by muscle weakness and myotonia. This condition is caused by a mutation in the DMPK gene, where a segment of DNA is abnormally expanded. The test involves analyzing a sample of the patient's DNA to detect the presence and size of the CTG triplet repeat expansion in the DMPK gene, which is responsible for the condition.
Administered at DNA Labs UAE, a leading facility in genetic testing, the Myotonic Dystrophy Type 1 Test is essential for accurate diagnosis and management of the disorder. It aids in confirming the diagnosis, understanding the severity of the condition, and guiding treatment decisions. Additionally, it can be useful for family planning and determining the risk of passing the condition to offspring.
The cost of the Myotonic Dystrophy Type 1 Test at DNA Labs UAE is set at 1400 AED. Given the complexity of the condition and the specialized nature of the test, this price reflects the comprehensive analysis and the detailed report provided by the lab. Individuals seeking this test can expect a reliable service backed by the expertise of DNA Labs UAE, ensuring accurate and timely diagnosis of Myotonic Dystrophy Type 1.
The "Warfarin Therapeutic Response Predictive Assay VKORC1 and CYP2C9 Test" is a specialized genetic test offered by DNA Labs UAE, priced at 1280 AED. This diagnostic tool is designed to evaluate an individual's genetic predisposition to respond to warfarin, a commonly prescribed anticoagulant medication used to prevent blood clots. The test focuses on analyzing specific genetic variants in two genes: VKORC1 and CYP2C9.
The VKORC1 gene encodes for a protein that is a key target of warfarin, while the CYP2C9 gene is involved in the metabolism of the drug. Variations in these genes can significantly affect how a person metabolizes warfarin, impacting the drug's efficacy and risk of side effects. By identifying these genetic variants, healthcare providers can tailor warfarin dosing to the individual's genetic makeup, enhancing treatment safety and effectiveness. This personalized approach to medication management aims to minimize the risk of bleeding complications or thrombosis, ensuring optimal therapeutic outcomes for patients on warfarin therapy.
The Factor V Leiden Detection RNA Qualitative Test is a specialized diagnostic procedure designed to identify the presence of the Factor V Leiden mutation, a genetic variation that can significantly increase the risk of developing abnormal blood clots. This test specifically targets and analyzes RNA to detect the mutation, offering a qualitative assessment, meaning it determines whether the mutation is present or not, without quantifying the amount of mutated gene.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for individuals with a family history of blood clotting disorders or those who have experienced unexplained thrombotic events. By identifying the mutation, healthcare providers can tailor treatment and management plans to reduce the risk of clot-related complications.
The cost of the Factor V Leiden Detection RNA Qualitative Test at DNA Labs UAE is set at 1200 AED. This investment in health allows individuals to take proactive steps in managing their well-being, particularly in preventing potentially life-threatening conditions associated with the Factor V Leiden mutation.
The "Histoplasma RNA Detection Qualitative Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify the presence of RNA from the Histoplasma fungus in a patient's sample. Histoplasmosis, the disease caused by this fungus, can range from mild to severe and is particularly dangerous in individuals with weakened immune systems. The test employs sophisticated molecular techniques to qualitatively detect the RNA, thereby confirming or ruling out an infection. This is crucial for the timely and appropriate management of the disease. The cost of the test is 1360 AED, reflecting the advanced technology and expertise required to accurately perform the analysis. By offering this test, DNA Labs UAE provides an essential tool for the diagnosis of histoplasmosis, aiding healthcare providers in delivering targeted treatment to affected patients.
The "JEV RNA Detection RNA Detection Qualitative Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying the presence of Japanese Encephalitis Virus (JEV) RNA in patient samples. This qualitative test utilizes advanced molecular techniques to detect the genetic material of the virus, providing a reliable indicator of infection. Japanese Encephalitis is a mosquito-borne viral infection that affects the central nervous system and can lead to severe complications and even death, making early and accurate detection crucial for effective management and treatment.
The test is priced at 1360 AED, reflecting the sophisticated technology and expertise required to perform this analysis. By detecting the virus's RNA, the test can confirm the presence of the virus even before antibodies are detectable, offering a significant advantage in early diagnosis and intervention. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is an essential tool in the fight against Japanese Encephalitis, providing patients and healthcare providers with critical information for timely and appropriate action.
The M. Leprosy Bacterial Load Test is a diagnostic assessment designed to detect and quantify the presence of Mycobacterium leprae, the bacterium responsible for leprosy, also known as Hansen's disease. This test is crucial for the accurate diagnosis and management of leprosy, a chronic infectious disease that primarily affects the skin, peripheral nerves, mucosal surfaces of the upper respiratory tract, and the eyes. Early detection and quantification of the bacterial load can significantly influence treatment choices and outcomes, enabling healthcare providers to tailor interventions more effectively and monitor the disease's progression or response to therapy.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test utilizes sophisticated molecular techniques to ensure high sensitivity and specificity in detecting the genetic material of M. leprae. The cost of the test is set at 1360 AED, reflecting the advanced technology and expertise required to conduct this specialized analysis. Patients undergoing this test at DNA Labs UAE can expect a professional service that contributes to the comprehensive care and management of leprosy, facilitating early intervention and reducing the risk of long-term complications associated with the disease.
The "Malaria P. Falciparum and P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test" is a highly specialized diagnostic procedure aimed at identifying and differentiating between two of the most common and dangerous strains of malaria: Plasmodium falciparum and Plasmodium vivax. Utilizing cutting-edge RNA detection technology, this test offers a qualitative analysis, meaning it can confirm the presence of these parasites in the blood but does not quantify their levels.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, this test represents a crucial tool in the fight against malaria, enabling healthcare providers to tailor treatment strategies effectively. The cost of the test is set at 1360 AED, reflecting the sophisticated technology and expertise involved in its execution. Early and accurate detection through such advanced diagnostics is vital in managing malaria, reducing its spread, and minimizing its impact on affected populations.
The Malassezia Species Quantitative Test is a specialized diagnostic procedure aimed at identifying and quantifying the presence of Malassezia yeast species within a sample. This test is particularly relevant in the field of dermatology, as Malassezia yeasts are known to be associated with various skin conditions, including dandruff, seborrheic dermatitis, and pityriasis versicolor. By accurately determining the species and quantity of Malassezia present, healthcare providers can tailor treatment strategies more effectively to manage and alleviate symptoms associated with its overgrowth.
Conducted at DNA Labs UAE, a facility renowned for its advanced diagnostic technologies and expert staff, the test ensures high accuracy and reliability. The process involves collecting a sample from the affected area of the skin, which is then analyzed using molecular techniques to detect and quantify the Malassezia species.
The cost of the Malassezia Species Quantitative Test at DNA Labs UAE is set at 1360 AED. This price reflects the sophisticated nature of the testing process and the valuable insights it provides for both patients and clinicians in addressing skin health issues linked to Malassezia yeast.
The "Plasmodium Species Quantitative Test" is a specialized diagnostic procedure aimed at detecting and quantifying the presence of Plasmodium parasites, which are the causative agents of malaria, in the human body. This test is particularly crucial in regions where malaria is endemic, as it aids in the accurate diagnosis and management of the disease. By employing advanced molecular techniques, this test can identify the specific species of Plasmodium (e.g., P. falciparum, P. vivax, P. malariae, and P. ovale) infecting the individual, which is essential for choosing the most effective treatment regimen.
Performed at DNA Labs UAE, a state-of-the-art facility known for its commitment to providing accurate and reliable diagnostic services, the Plasmodium Species Quantitative Test is conducted under strict quality controls. The test cost is set at 1360 AED, reflecting the sophisticated technology and expertise involved in its execution. This investment is invaluable for patients seeking a precise diagnosis of malaria, enabling timely and appropriate medical intervention.
The "Proteus Vulgaris Bacterial Load Test" is a diagnostic procedure designed to identify and quantify the presence of the Proteus vulgaris bacterium in a sample. This bacterium is known for causing urinary tract infections and other opportunistic infections, particularly in individuals with compromised immune systems. The test involves collecting a sample from the patient, which could be urine, blood, or tissue, depending on the suspected site of infection. This sample is then cultured and analyzed in a laboratory setting to detect the presence of Proteus vulgaris and determine its concentration. Understanding the bacterial load is crucial for guiding treatment decisions, such as the selection of appropriate antibiotics and the determination of treatment duration.
The test is offered at DNA Labs UAE, a state-of-the-art facility known for its comprehensive range of diagnostic services. The cost of the Proteus Vulgaris Bacterial Load Test at DNA Labs UAE is 1360 AED. This price reflects the sophisticated nature of the testing process, which involves advanced microbiological techniques and the expertise of skilled laboratory personnel. Patients opting for this test at DNA Labs UAE can expect accurate and timely results, which are essential for effective management of infections caused by Proteus vulgaris.
